Login / Signup
Zoran Andrić
ORCID
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 2
Top Topics
Randomized Controlled Trial
Replacement Therapy
Squamous Cell Carcinoma
Open Label
Top Venues
Future oncology (London, England)
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Joshua Tobias
,
Marina Maglakelidze
,
Zoran Andrić
,
Dinara Ryspayeva
,
Iurie Bulat
,
Ivan Nikolić
,
Zoran Petrovic
,
Tanuj Chawla
,
Rajnish Nagarkar
,
Erika Garner-Spitzer
,
Christoph C Zielinski
,
Leslie Mi Ok Chong
,
Bonnie Nixon
,
Nicholas J Ede
,
Sharon Yavrom
,
Michael Kundi
,
Ursula Wiedermann
Phase II trial of HER-Vaxx, a B cell peptide-based vaccine, in HER2-overexpressing advanced gastric cancer patients under platinum-based chemotherapy (HERIZON).
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)
Shom Goel
,
Antoinette R Tan
,
Hope S Rugo
,
Philippe Aftimos
,
Zoran Andrić
,
Andrew P Beelen
,
Jingshan Zhang
,
John S Yi
,
Rajesh K Malik
,
Joyce O'Shaughnessy
Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2.
Future oncology (London, England)
(2022)